Brewing Better Health: Landmark Study Uncovers the Biological Ties Between Coffee and Liver Resilience on August 19, 2026 Posted by
Regaining Mobility: The 10-Minute Wall Routine to Rebuild Knee Strength After 60 on August 19, 2026 Posted by
The Circadian Anchor: Navigating the Complex Relationship Between Sleep and Bipolar Disorder on August 19, 2026 Posted by
Executive Shuffle: Anita Zielinski Departs Baxter to Lead Accounting at Cardinal Health on August 19, 2026 Posted by
Pulse of Contention: Physicians Challenge Big 12’s Monster Energy Partnership Amid Pediatric Health Fears on August 19, 2026 Posted by
The Kratom Paradox: Navigating the Complexities of a Controversial Botanical on August 19, 2026 Posted by
Mimicking the Complexity of Life: How Texas A&M’s New "Vessel-Chips" Are Revolutionizing Vascular Medicine on August 19, 2026 Posted by
Brewing Better Health: Landmark Study Uncovers the Biological Ties Between Coffee and Liver Resilience on August 19, 2026 Posted by
Regaining Mobility: The 10-Minute Wall Routine to Rebuild Knee Strength After 60 on August 19, 2026 Posted by
The Circadian Anchor: Navigating the Complex Relationship Between Sleep and Bipolar Disorder on August 19, 2026 Posted by
Executive Shuffle: Anita Zielinski Departs Baxter to Lead Accounting at Cardinal Health on August 19, 2026 Posted by
Posted in Medical Innovations New Hope for Advanced Lung Cancer: FDA Approves Zidesamtinib for Pre-Treated ROS1-Positive NSCLC on July 23, 2026
Posted in Respiratory Health Precision Oncology Milestone: GSK’s Jideytro (Zidesamtinib) Receives Landmark FDA Approval for ROS1-Positive NSCLC on July 22, 2026
Posted in Medical Innovations A New Horizon in Oncology: Bispecific Antibody Ivonescimab Sets a Higher Bar for Squamous NSCLC Treatment on June 1, 2026 rifanmuazin
Posted in Medical Innovations A New Era in Lung Cancer Care: Selpercatinib Establishes Standard for RET Fusion-Positive NSCLC on May 31, 2026 rifanmuazin
Posted in Medical Innovations A New Frontier in Lung Cancer: Sunvozertinib Challenges Chemotherapy in First-Line NSCLC Treatment on May 30, 2026 rifanmuazin
